AGs Express Concern about Pain Management Best Practices Inter-Agency Task Force Draft Report

The Draft Report should be revised to clearly state that there is no completely safe opioid dose, and that higher doses are particularly – and predictably – risks.

Read More →

NAAG Supports Equal Coronavirus Relief Funding for the District of Columbia

We believe that the District should receive $1.25 billion for purposes of the relief package. The District has nearly 200 confirmed coronavirus cases, which outpaces nearly two dozen states and territories. Indeed, as a densely populated urban center, the District is uniquely vulnerable to the spread of the virus and is already experiencing significant economic loss due to the ongoing public health emergency.

Read More →

NAAG Urges FDA to Include AGs in Oversight of Cannabis-Derived Products

As the primary enforcers of our respective states’ consumer protection laws, we offer a unique perspective as to the new legalized market of certain cannabis and cannabis-derived compounds, including CBD products. We write to express our hope that the FDA continues to explore manufacturing, testing, and marketing best practices so that consumers are not at risk of misleading advertising or harm to their health from dangerous additives or undisclosed risks of use. Although products containing cannabis or cannabis-derived compounds may well offer real benefits to consumers, it is important that consumers have reliable risk and benefit information to make informed choices about initiating and continuing the use of these products. A crucial element of FDA regulation and oversight should be an on-going assessment of the potential risks or benefits of these products, particularly for specific populations such as pregnant women, adolescents and children, and the elderly. How these products interact with other dietary or pharmaceutical products should be included in this assessment. It is also important that companies not mislead consumers. Scientific and medical data from the FDA would assist in meaningful enforcement of advertising laws and regulations by the states.

Read More →

State AGs Support Amendment to Communications Decency Act

In 2013 and again in 2017, Attorneys General from virtually every state and territory wrote to inform Congress of a damaging misinterpretation and misapplication of Section 230 of the Communications Decency Act of 1996 (CDA) that rendered state and local authorities unable to enforce criminal laws against companies that actively profited from the promotion and facilitation of sex trafficking and crimes against children. To be sure, we are grateful for all the work you have done to protect the vulnerable among us. To bootstrap your efforts, we renew our recommendation for a modest but necessary amendment to the CDA. We must enable our state and local authorities to protect our citizens, including the most vulnerable among us, and to take appropriate action against criminal actors.

Read More →

State AGs Endorse TRACED Act to Combat Illegal Robocalls

We believe that this legislation effectively addresses many of the concerns raised by federal regulators, voice service providers, private businesses, consumer advocacy groups, and other interested parties to combat illegal robocalls and spoofing, and we are heartened that it enables the telecom industry, federal regulators, and our offices to take meaningful steps to abate the rapid proliferation of these illegal and unwanted robocalls.

Read More →

AGs Send Policy Guidelines to Streaming Industry to Combat Youth Tobacco Use

Given the recent significant rise in tobacco use by young people, particularly the use of e-cigarettes, preventing initiation and use of tobacco products is of critical importance to us and the public health community, and we sincerely hope it will be addressed by the streaming industry.

Read More →